Publications
Detailed Information
Dynamic changes of oligomeric amyloid β levels in plasma induced by spiked synthetic Aβ42
DC Field | Value | Language |
---|---|---|
dc.contributor.author | An, Seong Soo A. | - |
dc.contributor.author | Lee, Byoung-sub | - |
dc.contributor.author | Yu, Ji Sun | - |
dc.contributor.author | Lim, Kuntaek | - |
dc.contributor.author | Kim, Gwang Je | - |
dc.contributor.author | Lee, Ryan | - |
dc.contributor.author | Kim, Shinwon | - |
dc.contributor.author | Kang, Sungmin | - |
dc.contributor.author | Park, Young Ho | - |
dc.contributor.author | Wang, Min Jeong | - |
dc.contributor.author | Yang, Young Soon | - |
dc.contributor.author | Youn, Young Chul | - |
dc.contributor.author | Kim, SangYun | - |
dc.date.accessioned | 2017-11-03T06:19:55Z | - |
dc.date.available | 2017-11-03T15:20:46Z | - |
dc.date.issued | 2017-10-17 | - |
dc.identifier.citation | Alzheimer's Research & Therapy, 9(1):86 | ko_KR |
dc.identifier.issn | 1758-9193 | - |
dc.identifier.uri | https://hdl.handle.net/10371/138334 | - |
dc.description.abstract | Abstract
Background A reliable blood-based assay is required to properly diagnose and monitor Alzheimers disease (AD). Many attempts have been made to develop such a diagnostic tool by measuring amyloid-β oligomers (AβOs) in the blood, but none have been successful in terms of method reliability. We present a multimer detection system (MDS), initially developed for the detection of prion oligomers in the blood, to detect AβOs. Methods To characterize Aβ in the blood, plasma was spiked with synthetic amyloid-β (Aβ) and incubated over time. Then, the MDS was used to monitor the dynamic changes of AβO levels in the plasma. Results Increasing concentrations of AβOs were observed in the plasma of patients with AD but not in the plasma of normal control subjects. The plasma from patients with AD (n = 27) was differentiated from that of the age-matched normal control subjects (n = 144) with a sensitivity of 83.3% and a specificity of 90.0%. Conclusions Synthetic Aβ spiked into the blood plasma of patients with AD, but that of not elderly normal control subjects, induced dynamic changes in the formation of AβOs over time. AβOs were detected by the MDS, which is a useful blood-based assay with high sensitivity and specificity for AD diagnosis. | ko_KR |
dc.description.sponsorship | This work was supported by grants from the Korean Health Technology R&D Project (HI14C3331) through the Korean Health Industry Development Institute (KHIDI), the Korean Ministry of Health & Welfare, and the National Research Foundation of Korea (NRF-2017R1A2B4012636). | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | BioMed Central | ko_KR |
dc.subject | Multimer detection system | ko_KR |
dc.subject | Alzheimer’s disease | ko_KR |
dc.subject | Amyloid-β | ko_KR |
dc.subject | Oligomers | ko_KR |
dc.subject | Blood biomarker | ko_KR |
dc.subject | Synthetic amyloid-β | ko_KR |
dc.subject | ELISA | ko_KR |
dc.subject | Plasma test | ko_KR |
dc.title | Dynamic changes of oligomeric amyloid β levels in plasma induced by spiked synthetic Aβ42 | ko_KR |
dc.type | Article | ko_KR |
dc.contributor.AlternativeAuthor | 안성수 | - |
dc.contributor.AlternativeAuthor | 이병섭 | - |
dc.contributor.AlternativeAuthor | 유지선 | - |
dc.contributor.AlternativeAuthor | 임근택 | - |
dc.contributor.AlternativeAuthor | 김광제 | - |
dc.contributor.AlternativeAuthor | 김신원 | - |
dc.contributor.AlternativeAuthor | 강성민 | - |
dc.contributor.AlternativeAuthor | 박영호 | - |
dc.contributor.AlternativeAuthor | 왕민정 | - |
dc.contributor.AlternativeAuthor | 양영순 | - |
dc.contributor.AlternativeAuthor | 윤영철 | - |
dc.contributor.AlternativeAuthor | 김상윤 | - |
dc.identifier.doi | 10.1186/s13195-017-0310-6 | - |
dc.language.rfc3066 | en | - |
dc.rights.holder | The Author(s). | - |
dc.date.updated | 2017-10-23T16:47:35Z | - |
- Appears in Collections:
- Files in This Item:
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.